Claims for Patent: 9,192,695

Summary for Patent: 9,192,695

Title:	Allografts combined with tissue derived stem cells for bone healing
Abstract:	There is disclosed a method of combining mesenchymal stem cells (MSCs) with a bone substrate. In an embodiment, the method includes obtaining tissue having MSCs together with unwanted cells. The tissue is digested to form a cell suspension having MSCs and unwanted cells. The cell suspension is added to the substrate and the MSCs are allowed to adhere. The substrate is rinsed to remove unwanted cells. In an embodiment, there is disclosed an allograft product including a combination of MSCs with a bone substrate made according to the described method. Other embodiments are also disclosed.
Inventor(s):	Shi; Yaling (Larkspur, CO)
Assignee:	AlloSource (Centennial, CO)
Application Number:	12/612,583
Patent Claims:	1. A method of making an allograft product for enhancing bone formation, the method consisting of: providing a bone substrate obtained from a human, cadaveric donor; providing adipose tissue comprising mesenchymal stem cells and unwanted cells from the human, cadaveric donor; digesting and centrifuging the adipose tissue to form a stromal vascular fraction pellet comprising the mesenchymal stem cells and the unwanted cells; adding the stromal vascular fraction pellet to the bone substrate to form a seeded bone substrate; incubating the seeded bone substrate for a period of time to allow the mesenchymal stem cells to adhere to the bone substrate; and rinsing the seeded bone substrate to remove the unwanted cells from the bone substrate; thereby making the allograft product for enhancing bone formation, wherein the allograft product comprises bone substrate with mesenchymal stem cells adhered thereto. 2. A method in accordance with claim 1, wherein the digesting the adipose tissue comprises making a collagenase I solution, filtering the collagenase I solution through a 0.2 .mu.m filter unit, mixing the adipose tissue with the collagenase I solution, and placing the adipose tissue with the collagenase I solution into a shaker flask. 3. A method in accordance with claim 2, wherein the digesting the adipose tissue further comprises agitating the shaker flask with continuous agitation at about 75 RPM for about 45 to 60 minutes to form digested adipose tissue. 4. A method in accordance with claim 1, wherein the centrifuging the adipose tissue comprises centrifuging the digested adipose tissue to form a supernatant containing mature adipocytes and the stromal vascular fraction pellet, and aspirating the supernatant to remove it from the stromal vascular fraction pellet. 5. A method in accordance with claim 1, wherein the bone substrate comprises bone tissue that has been subjected to a demineralization process. 6. A method in accordance with claim 1, wherein the bone substrate comprises cortical bone. 7. A method in accordance with claim 1, wherein the bone substrate comprises cancellous bone. 8. A method in accordance with claim 1, wherein the bone substrate comprises ground bone. 9. A method in accordance with claim 1, wherein the bone substrate comprises both cortical and cancellous bone. 10. A method in accordance with claim 1, wherein the bone substrate comprises demineralized cancellous bone. 11. A method in accordance with claim 1, wherein the bone substrate comprises fully demineralized bone or partially demineralized bone. 12. A method in accordance with claim 1, wherein adding the stromal vascular fraction pellet to the bone substrate involves disrupting the stromal vascular fraction pellet and suspending the mesenchymal stem cells and the unwanted cells in a volume of medium. 13. A method in accordance with claim 1, wherein the incubating is performed for about 1-3 days. 14. A method in accordance with claim 1, wherein the incubating is performed for no more than about 3 days. 15. A method in accordance with claim 1, wherein the incubating consists of incubating the seeded bone substrate in growth medium. 16. An allograft product including a combination of mesenchymal stem cells with a bone substrate, the allograft product manufactured by the method of claim 1. 17. A method of making an allograft product for enhancing bone formation, the method consisting of: providing a bone substrate obtained from a human, cadaveric donor; providing an adipose stromal vascular fraction pellet obtained by digesting and centrifuging adipose tissue from the human, cadaveric donor, the adipose stromal vascular fraction pellet comprising mesenchymal stem cells and unwanted cells; adding the stromal vascular fraction pellet to the bone substrate to form a seeded bone substrate; incubating the seeded bone substrate for a period of time to allow the mesenchymal stem cells to adhere to the bone substrate; and rinsing the seeded bone substrate to remove the unwanted cells from the bone substrate; thereby making the allograft product for enhancing bone formation, wherein the allograft product comprises bone substrate with mesenchymal stem cells adhered thereto. 18. A method in accordance with claim 17, wherein the adipose stromal vascular fraction is prepared by digesting adipose tissue obtained from the human, cadaveric donor, the digesting the adipose tissue comprises making a collagenase I solution, filtering the collagenase I solution through a 0.2 .mu.m filter unit, mixing the adipose tissue with the collagenase I solution, and placing the adipose tissue with the collagenase I solution to into a shaker flask. 19. A method in accordance with claim 18, wherein the digesting the adipose tissue further comprises agitating the shaker flask with continuous agitation at about 75 RPM for about45 to 60 minutes to form digested adipose tissue. 20. A method in accordance with claim 17, wherein the centrifuging the adipose tissue comprises centrifuging the digested adipose tissue to form a supernatant containing mature adipocytes and the stromal vascular fraction pellet, and aspirating the supernatant to remove it from the stromal vascular fraction pellet. 21. A method in accordance with claim 17, wherein the bone substrate comprises bone tissue that has been subjected to a demineralization process. 22. A method in accordance with claim 17, wherein the bone substrate comprises cortical bone. 23. A method in accordance with claim 17, wherein the bone substrate comprises cancellous bone. 24. A method in accordance with claim 17, wherein the bone substrate comprises ground bone. 25. A method in accordance with claim 17, wherein the bone substrate comprises both cortical and cancellous bone. 26. A method in accordance with claim 17, wherein the bone substrate comprises demineralized cancellous bone. 27. A method in accordance with claim 17, wherein the bone substrate comprises fully demineralized bone or partially demineralized bone. 28. A method in accordance with claim 17, wherein adding the stromal vascular fraction pellet to the bone substrate involves disrupting the stromal vascular fraction pellet and suspending the mesenchymal stem cells and the unwanted cells in a volume of medium. 29. A method in accordance with claim 17, wherein the incubating is performed for about 1-3 days. 30. A method in accordance with claim 17, wherein the incubating is performed for no more than about 3 days. 31. A method in accordance with claim 17, wherein the incubating consists of incubating the seeded bone substrate in growth medium. 32. An allograft product including a combination of mesenchymal stem cells with a bone substrate, the allograft product manufactured by the method of claim 17. 33. A method of making an allograft product for enhancing bone formation, the method consisting of: providing a bone substrate obtained from a human, cadaveric donor; providing adipose tissue comprising mesenchymal stem cells and unwanted cells from the human, cadaveric donor; digesting and centrifuging the adipose tissue to form a stromal vascular fraction pellet comprising the mesenchymal stem cells and the unwanted cells; adding the stromal vascular fraction pellet to the bone substrate to form a seeded bone substrate; incubating the seeded bone substrate for a period of time to allow the mesenchymal stem cells to adhere to the bone substrate; rinsing the seeded bone substrate to remove the unwanted cells from the bone substrate; and placing the seeded bone substrate into a cryopreservation medium; thereby making the allograft product for enhancing bone formation, wherein the allograft product comprises bone substrate with mesenchymal stem cells adhered thereto. 34. A method in accordance with claim 33, wherein the digesting the adipose tissue comprises making a collagenase I solution, filtering the collagenase I solution through a 0.2 .mu.m filter unit, mixing the adipose tissue with the collagenase I solution, and placing the adipose tissue with the collagenase I solution to into a shaker flask. 35. A method in accordance with claim 34, wherein the digesting the adipose tissue further comprises agitating the shaker flask with continuous agitation at about 75 RPM for about 45 to 60 minutes to form digested adipose tissue. 36. A method in accordance with claim 33, wherein the centrifuging the adipose tissue comprises centrifuging the digested adipose tissue to form a supernatant containing mature adipocytes and the stromal vascular fraction pellet, and aspirating the supernatant to remove it from the stromal vascular fraction pellet. 37. A method in accordance with claim 33, wherein the bone substrate comprises bone tissue that has been subjected to a demineralization process. 38. A method in accordance with claim 33, wherein the bone substrate comprises cortical bone. 39. A method in accordance with claim 33, wherein the bone substrate comprises cancellous bone. 40. A method in accordance with claim 33, wherein the bone substrate comprises ground bone. 41. A method in accordance with claim 33, wherein the bone substrate comprises both cortical and cancellous bone. 42. A method in accordance with claim 33, wherein the bone substrate comprises demineralized cancellous bone. 43. A method in accordance with claim 33, wherein the bone substrate comprises fully demineralized bone or partially demineralized bone. 44. A method in accordance with claim 33, wherein adding the stromal vascular fraction pellet to the bone substrate involves disrupting the stromal vascular fraction pellet and suspending the mesenchymal stem cells and the unwanted cells in a volume of medium. 45. A method in accordance with claim 33, wherein the incubating is performed for about 1-3 days. 46. A method in accordance with claim 33, wherein the incubating is performed for no more than about 3 days. 47. A method in accordance with claim 33, wherein the incubating consists of incubating the seeded bone substrate in growth medium. 48. An allograft product including a combination of mesenchymal stem cells with a bone substrate, the allograft product manufactured by the method of claim 33. 49. A method of making an allograft product for enhancing bone formation, the method consisting of: providing a bone substrate obtained from a human, cadaveric donor; providing an adipose stromal vascular fraction pellet obtained by digesting and centrifuging adipose tissue from the human, cadaveric donor, the adipose stromal vascular fraction pellet comprising mesenchymal stem cells and unwanted cells; adding the stromal vascular fraction pellet to the bone substrate to form a seeded bone substrate; incubating the seeded bone substrate for a period of time to allow the mesenchymal stem cells to adhere to the bone substrate; rinsing the seeded bone substrate to remove the unwanted cells from the bone substrate; and placing the seeded bone substrate into a cryopreservation medium; thereby making the allograft product for enhancing bone formation, wherein the allograft product comprises bone substrate with mesenchymal stem cells adhered thereto. 50. A method in accordance with claim 49, wherein the adipose stromal vascular fraction is prepared by digesting adipose tissue obtained from the human, cadaveric donor, the digesting the adipose tissue comprises making a collagenase I solution, filtering the collagenase I solution through a 0.2 .mu.m filter unit, mixing the adipose tissue with the collagenase I solution, and placing the adipose tissue with the collagenase I solution to into a shaker flask. 51. A method in accordance with claim 50, wherein the digesting the adipose tissue further comprises agitating the shaker flask with continuous agitation at about 75 RPM for about 45 to 60 minutes to form digested adipose tissue. 52. A method in accordance with claim 49, wherein the centrifuging the adipose tissue comprises centrifuging the digested adipose tissue to form a supernatant containing mature adipocytes and the stromal vascular fraction pellet, and aspirating the supernatant to remove it from the stromal vascular fraction pellet. 53. A method in accordance with claim 49, wherein the bone substrate comprises bone tissue that has been subjected to a demineralization process. 54. A method in accordance with claim 49, wherein the bone substrate comprises cortical bone. 55. A method in accordance with claim 49, wherein the bone substrate comprises cancellous bone. 56. A method in accordance with claim 49, wherein the bone substrate comprises ground bone. 57. A method in accordance with claim 49, wherein the bone substrate comprises both cortical and cancellous bone. 58. A method in accordance with claim 49, wherein the bone substrate comprises demineralized cancellous bone. 59. A method in accordance with claim 49, wherein the bone substrate comprises fully demineralized bone or partially demineralized bone. 60. A method in accordance with claim 49, wherein adding the stromal vascular fraction pellet to the bone substrate involves disrupting the stromal vascular fraction pellet and suspending the mesenchymal stem cells and the unwanted cells in a volume of medium. 61. A method in accordance with claim 49, wherein the incubating is performed for about 1-3 days. 62. A method in accordance with claim 49, wherein the incubating is performed for no more than about 3 days. 63. A method in accordance with claim 49, wherein the incubating consists of incubating the seeded bone substrate in growth medium. 64. An allograft product including a combination of mesenchymal stem cells with a bone substrate, the allograft product manufactured by the method of claim 49.

Details for Patent 9,192,695

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2028-11-20